Anlon Healthcare is currently trading at Rs. 120.40, up by 7.65 points or 6.78% from its previous closing of Rs. 112.75 on the BSE.

The scrip opened at Rs. 112.85 and has touched a high and low of Rs. 120.50 and Rs. 112.85 respectively. So far 6983 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 172.00 on 01-Dec-2025 and a 52 week low of Rs. 86.98 on 05-Sep-2025.

Last one week high and low of the scrip stood at Rs. 120.50 and Rs. 111.45 respectively. The current market cap of the company is Rs. 622.14 crore.

The promoters holding in the company stood at 52.68%, while Institutions and Non-Institutions held 4.72% and 42.60% respectively.

Anlon Healthcare has successfully completed the acquisition of 56.67% equity shareholding of Bizotic Life Science (target company) on March 20, 2026. Consequent to this acquisition, the target company becomes a subsidiary of Anlon Healthcare. 

Anlon Healthcare is a chemical manufacturing company engaged in manufacturing of pharmaceutical intermediates and Active Pharmaceutical Ingredients (APIs), which are supplied to customers both in ndia and international markets.